Select Total Liab from 2010 to 2024

SEM Stock  USD 39.67  0.60  1.54%   
Select Medical Total Liabilities yearly trend continues to be very stable with very little volatility. Total Liabilities is likely to drop to about 4.1 B. Total Liabilities is the total amount of all liabilities that Select Medical Holdings has, including both short-term and long-term liabilities. View All Fundamentals
 
Total Liabilities  
First Reported
2006-06-30
Previous Quarter
6.1 B
Current Value
5.7 B
Quarterly Volatility
1.8 B
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Select Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Select Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 135.3 M, Interest Expense of 152.3 M or Total Revenue of 4.2 B, as well as many indicators such as Price To Sales Ratio of 0.39, Dividend Yield of 0.021 or PTB Ratio of 2.36. Select financial statements analysis is a perfect complement when working with Select Medical Valuation or Volatility modules.
  
Check out the analysis of Select Medical Correlation against competitors.

Latest Select Medical's Total Liab Growth Pattern

Below is the plot of the Total Liab of Select Medical Holdings over the last few years. It is the total amount of all liabilities that a company has, including both short-term and long-term liabilities. Select Medical's Total Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Select Medical's overall financial position and show how it may be relating to other accounts over time.
Total Liab10 Years Trend
Slightly volatile
   Total Liab   
       Timeline  

Select Total Liab Regression Statistics

Arithmetic Mean4,174,469,637
Geometric Mean3,783,656,914
Coefficient Of Variation42.80
Mean Deviation1,505,812,339
Median4,055,581,548
Standard Deviation1,786,522,524
Sample Variance3191662.7T
Range4.5B
R-Value0.84
Mean Square Error1015859T
R-Squared0.70
Significance0.000091
Slope335,288,314
Total Sum of Squares44683278.2T

Select Total Liab History

20244.1 B
20236.1 B
20226.3 B
2021B
20206.4 B
20196.4 B
2018B

About Select Medical Financial Statements

Select Medical investors utilize fundamental indicators, such as Total Liab, to predict how Select Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Total Liabilities6.1 B4.1 B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Select Medical Holdings is a strong investment it is important to analyze Select Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Select Medical's future performance. For an informed investment choice regarding Select Stock, refer to the following important reports:
Check out the analysis of Select Medical Correlation against competitors.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Select Medical. If investors know Select will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Select Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.139
Dividend Share
0.5
Earnings Share
2.14
Revenue Per Share
56.158
Quarterly Revenue Growth
0.057
The market value of Select Medical Holdings is measured differently than its book value, which is the value of Select that is recorded on the company's balance sheet. Investors also form their own opinion of Select Medical's value that differs from its market value or its book value, called intrinsic value, which is Select Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Select Medical's market value can be influenced by many factors that don't directly affect Select Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Select Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Select Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Select Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.